Keloid
A keloid is a benign fibroproliferative scar that grows beyond the margins of the original wound and rarely regresses, treated first-line with intralesional triamcinolone acetonide 10-40 mg/mL every 4-6 weeks.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Fibroproliferative scar that outgrows the wound: a benign dermal growth of disorganized, excess collagen that extends beyond the borders of the original skin injury, forming firm, raised, shiny…
- Epidemiology
Darker skin pigmentation: incidence is markedly increased in Fitzpatrick skin types IV-VI compared with lighter skin.
- Risk factors
Darker skin pigmentation: the single strongest risk factor.
- Pathophysiology
Excess TGF-beta drives fibroblast overactivity: aberrant TGF-beta signaling sustains fibroblast proliferation and collagen synthesis well beyond normal wound remodeling.
- Clinical features
Firm, raised nodule or plaque extending beyond the wound: the hallmark finding is scar tissue that has grown past the borders of the original injury, often with clawlike projections; this extension is what clinically defines a keloid.
- Differential diagnosis
Hypertrophic scar: stays confined within the original wound margin, arises earlier (within weeks of injury), and commonly regresses over months, versus a keloid, which extends beyond the wound, can…
- Diagnosis
Clinical diagnosis based on morphology and history: keloid is diagnosed clinically; the defining criterion is fibrotic tissue extending beyond the margins of the original wound, with a history of…
- Management
First line, intralesional triamcinolone acetonide 10-40 mg/mL: Small or thin papules: 5-10 mg/mL.
- Complications
Recurrence after treatment: common even with combined excision plus adjuvant therapy; excision alone carries a particularly high recurrence rate, often exceeding 50%.
- Prognosis
Rarely regresses without treatment: an untreated keloid continues to grow slowly over years rather than flattening spontaneously.
- Prevention
Avoid elective procedures at high-risk sites in a known keloid-forming patient: counsel against ear piercing, elective cosmetic surgery, and tattooing at the earlobe, shoulder, presternal chest, and jawline.
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.